CA
RGEN icon

Calton & Associates’s Repligen RGEN Stock Holding History

Calton & Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,089
Closed -$204K – 330
2022
Q1 		$204K Sell
1,089
-184
-14% -$35K 0.06% 328
2021
Q4 		$337K Sell
1,273
-25
-2% -$6.74K 0.09% 237
2021
Q3 		$375K Buy
1,298
+40
+3% +$10.3K 0.08% 244
2021
Q2 		$251K Sell
1,258
-39
-3% -$7.57K 0.05% 327
2021
Q1 		$252K Sell
1,297
-4
-0.3% -$820 0.05% 320
2020
Q4 		$249K Sell
1,301
-171
-12% -$31.1K 0.04% 306
2020
Q3 		$217K Sell
1,472
-232
-14% -$33.2K 0.04% 300
2020
Q2 		$211K Buy
+1,704
New +$200K 0.05% 295
2020
Q1 		– Sell
-3,378
Closed -$312K – 367
2019
Q4 		$312K Buy
3,378
+44
+1% +$3.7K 0.06% 253
2019
Q3 		$256K Buy
+3,334
New +$292K 0.06% 268

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Calton & Associates's RGEN Position: Q2 2022 in Review

Calton & Associates sold out of Repligen (RGEN) in Q2 2022, closing a stake of 1,089 shares — an estimated $204K sold.

Calton & Associates first reported a position in RGEN in Q3 2019 and held it in 10 quarters. The position peaked at $375K in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Calton & Associates reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Calton & Associates sold 1,089 Repligen shares in Q2 2022, an estimated $204K.
  • Calton & Associates first reported a position in Repligen in Q3 2019 and held it in 10 quarters.
  • Calton & Associates's Repligen position peaked at $375K in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Calton & Associates's 13F filing for Q2 2022, filed 12 Jul 2022.